Literature DB >> 1145672

In vitro metabolism studies of (1, 2, 6, 7-3-H)-cortisol in human gingiva in health and disease.

T M Elattar.   

Abstract

The major conversion products of incubation of 3-H-cortisol with slices of human clinically normal and inflamed gingiva were identified as 11beta-hydroxyandrostenedione and cortisone. Reduction of C-20 of cortisol to 20alpha- and 20beta-dihydro metabolites was found only after incubation of cortisol with normal gingiva and not with inflamed tissue. Thus the two major pathways of metabolism of cortisol in the gingiva appear to be the oxidative cleavage of the side chain and the oxidation of 11beta-ol while the reduction of the 20-one appear limited to the normal tissue. The mean rates of conversion of cortisol to its various metabolites in 12 normal and 12 chronically inflamed gingival tissue samples were 147 and 55.2 pmoles hr-1-mg-1 respectively. The less conversion of cortisol in inflamed tissue might explain its effectiveness as a naturally occuring antiinflammatory hormonal steroid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1145672     DOI: 10.1016/0039-128x(75)90092-6

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  2 in total

1.  Gingival, plasma and salivary levels of melatonin in periodontally healthy individuals and chronic periodontitis patients: a pilot study.

Authors:  Thodur Madapusi Balaji; Hannah Rachel Vasanthi; Suresh Ranga Rao
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity.

Authors:  Ruth A Morgan; Katharina R Beck; Mark Nixon; Natalie Z M Homer; Andrew A Crawford; Diana Melchers; René Houtman; Onno C Meijer; Andreas Stomby; Anna J Anderson; Rita Upreti; Roland H Stimson; Tommy Olsson; Tom Michoel; Ariella Cohain; Arno Ruusalepp; Eric E Schadt; Johan L M Björkegren; Ruth Andrew; Christopher J Kenyon; Patrick W F Hadoke; Alex Odermatt; John A Keen; Brian R Walker
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.